Research Topics
Species | Mattia IntraSummaryAffiliation: European Institute of Oncology Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsyMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141, Milan, Italy
Ann Surg Oncol 12:895-9. 2005..Although a previous SLNB is often considered a contraindication for a subsequent SLNB, few data support this concern...
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breastMattia Intra
Department of Breast Surgery, European Institute of Oncology, Milan, Italy
Arch Surg 138:309-13. 2003....
Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 proceduresMattia Intra
Division of Breast Surgery, European Institute of Oncology, University of Milan, Milan, Italy
Surgery 140:467-71. 2006
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institutionMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Cancer 101:905-12. 2004..Synchronous bilateral invasive breast carcinoma (SBIBC) ranged in incidence from 0.3% to as high as 12%...
Full-dose intraoperative radiotherapy with electrons in breast surgery: broadening the indicationsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Arch Surg 140:936-9. 2005....
Intraoperative radiotherapy during breast conserving surgery in patients previously treated with radiotherapy for Hodgkin's diseaseMattia Intra
Department of Breast Surgery, University of Milan, Italy
Tumori 90:13-6. 2004..Mastectomy is therefore recommended as the preferred treatment option in these women...
Sentinel lymph node metastasis in microinvasive breast cancerMattia Intra
Department of Surgery, Breast Unit, University of Milan School of Medicine, Milan, Italy
Ann Surg Oncol 10:1160-5. 2003..Sentinel lymph node biopsy (SLNB) may obviate the need for CAD in these patients without compromising the staging of the axilla and the important prognostic information...
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 yearsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Ann Surg 247:315-9. 2008....
When sentinel lymph node is intramammaryMattia Intra
Breast Surgery Department, European Institute of Oncology, Via Ripamonti 435, Milan, MI 20141, Italy
Ann Surg Oncol 15:1304-8. 2008..Little attention has been placed to the presence of intramammary sentinel lymph nodes (intraMSLNs) on preoperative lymphoscintigraphy...
Unnecessary axillary node dissections in the sentinel lymph node eraMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy
Eur J Cancer 43:2664-8. 2007..As the clinical indications to SNB are progressively extending to encompass most breast cancer patients with non-metastatic disease who were previously excluded, great effort should be made to avoid 'unnecessary ALNDs'...
Second axillary sentinel node biopsy for ipsilateral breast tumour recurrenceM Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Br J Surg 94:1216-9. 2007..If axillary nodes remain clinically uninvolved after a previous negative SLNB the question remains whether second SLNB is a suitable option...
A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT)Mattia Intra
Department of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res 7:R828-32. 2005..Mastectomy is therefore recommended as the first option treatment in these women...
Local therapy for breast cancer in malignant lymphoma survivorsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast 20:S99-103. 2011..We performed a retrospective review to assess the potential of performing breast conservative surgery and intraoperative radiotherapy with electrons (ELIOT), in these patients...
A rare association of synchronous intraductal carcinoma of the breast and invasive carcinoma of ectopic breast tissue of the vulva: case report and literature reviewM Intra
Division of Breast Surgery, University of Milan School of Medicine, Milano, Italy
Int J Gynecol Cancer 16:428-33. 2006..The presence of a pure DCIS of the breast makes this case really unique, definitively confirming the independent primary origin of both mammary tumors. The inguinal sentinel node biopsy avoided a bilateral inguinal dissection...
Sentinel lymph node biopsy is feasible even after total mastectomyMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
J Surg Oncol 95:175-9. 2007..Previous mastectomy is unanimously considered to represent an absolute technical contraindication to sentinel lymph node biopsy (SLNB)...
Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancerMattia Intra
Breast Division, University of Milan, Italy
Arch Surg 137:737-40. 2002..In our experience, IORT for limited-stage breast carcinoma is easy to perform and only briefly prolongs the duration of the surgical procedure...
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 casesUmberto Veronesi
Istituto Europeo di Oncologia, Division of Radiotherapy, Istituto Europeo di Oncologia, Milan, Italy
Ann Surg 242:101-6. 2005..The new mobile linear accelerators easily moved close to the operating table to allow the full-dose irradiation during surgery...
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyUmberto Veronesi
Scientific Direction, European Institute of Oncology, Milan, Italy
Lancet Oncol 7:983-90. 2006..Results of our previous trial showed that SLNB accurately screens the ALN for metastasis in breast cancers of diameter 2 mm or less. We aimed to update this trial with results from longer follow-up...
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancerAndrea Rocca
Unit of Research in Medical Senology, Department of Medicine, Division of Pathology, University of Milan School of Medicine, Italy
Anticancer Drugs 17:1201-9. 2006..Perioperative chemotherapy failed to show an increase in the pathological complete remission rate. A biological effect on Ki-67 expression was demonstrated...
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivityGiuseppe Viale
Division of Pathology, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 116:317-28. 2009..EGFR immunoreactivity significantly correlates with worse prognosis in patients with triple-negative IDC, supporting further studies on the correlation between the degree of EGFR expression and outcome of triple negative breast cancer...
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissectionUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Eur J Cancer 41:231-7. 2005..The 5 year overall survival rate of the whole series was 98%. Patients with negative sentinel node biopsies not submitted to axillary dissection show during follow-up a rate of overt axillary metastases that is lower than that expected...
Positive axillary sentinel lymph node: is axillary dissection always necessary?Viviana Galimberti
Division ofSenology, European Institute of Oncology, Milan, Italy
Breast 20:S96-8. 2011..Ancillary analyses of the IBCSG 23-01 and AMAROS trials, still in follow-up, may be able to do this...
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?Viviana Galimberti
Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 131:819-25. 2012..Nevertheless, a subset of patients might be at high risk of developing overt axillary disease and efforts should be made to identify such patients by ancillary analyses of the results of ongoing or recently published clinical trials...
Conservative treatment of breast cancer: its evolutionAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 94:195-8. 2005..From an oncological perspective, outcome was found to be equally effective, and this key observation provided us with significant impetus to investigate the effects of reducing the radiotherapy field...
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatmentJean Yves Petit
Division of Plastic Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 96:47-51. 2006..In fact, although removal of the NAC greatly increases the patient's sensation of mutilation, and the risk of tumor involvement of the areola is reported as a very variable percentage, NAC excision still remains the standard treatment...
Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancerMario Ciocca
Department of Medical Physics, European Institute of Oncology, Milano, Italy
Radiother Oncol 78:213-6. 2006..In the present study, a further step was made, aiming at the improvement of the effectiveness of in vivo dosimetry, based on a real-time check of the dose...
Sentinel lymph node biopsy in male patients with early breast cancerOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, 20141, Milan, Italy
Oncologist 12:512-5. 2007..After a median follow-up of 30 months (range, 1-63) no axillary reappearance of the disease occurred. As with women, we recommend SLNB in male patients with breast cancer and clinically negative axilla...
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electronsUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 124:141-51. 2010..4 and 89.7%. ELIOT appears a promising feature in early breast cancer treated with breast conserving surgery, reducing the exposure of normal tissues to radiations and shortening the radiation course from 6 weeks to one single session...
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled studyUmberto Veronesi
European Institute of Oncology, Milan, Italy
Ann Surg 251:595-600. 2010..We present 10-year follow-up of our single-institute trial designed to compare outcomes in patients who received no axillary dissection if the sentinel node was negative, with patients who received complete axillary dissection...
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancerUmberto Veronesi
Division of Senology, European Institute of Oncology, Milan, Italy
N Engl J Med 349:546-53. 2003..Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy require validation...
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcomeOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
J Surg Oncol 94:375-9. 2006..To evaluate the ipsilateral breast tumor reappearance (IBTR) rate after breast conservative surgery (BCS) following primary chemotherapy (PC) and to assess whether positive margins affects IBTR rate and overall survival (OS)...
Breast-conserving surgery in 201 very young patients (<35 years)Oreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 19:55-8. 2010..Surgical treatment of breast cancer in very young patients (<35 years) is still a matter of debate, since age is a predictive factor of local recurrence after breast conservation...
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapyMarco Colleoni
Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 116:359-69. 2009..4, 95% CI 3.5-11.6, for DFS; HR 3.6 95% CI 2.4-5.6 for OS). Response and outcome after PCT are correlated with the degree of expression of steroid hormone receptors. Studies on tailored preoperative therapies are needed...
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni
Division of Medical Oncology, Department of Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milan, Italy
J Clin Oncol 23:1379-89. 2005....
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 yearsAliana Guerrieri-Gonzaga
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
Oncologist 14:201-12. 2009..We analyzed risk factors and treatment outcome in a large series of women treated at one institution...
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activityEmilia Montagna
Department of Medicine, European Institute of Oncology, Milan, Italy
Clin Breast Cancer 12:207-14. 2012..The analysis of the results suggests that the metronomic chemotherapy combined with bevacizumab and erlotinib is effective and well tolerated...
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatmentMarco Colleoni
Department of Medicine, European Institute of Oncology, Milan, Italy
Clin Cancer Res 10:6622-8. 2004..The purpose of this research was to identify factors predicting response to preoperative chemotherapy...
Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patientsViviana Galimberti
Divisions of Senology, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 9:924-8. 2002..Use of lymphoscintigraphy to visualize sentinel nodes reveals that IMNs often receive lymph from the area containing the tumor...
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptorsRosalba Torrisi
Research Unit in Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 17:654-60. 2008..Endocrine therapy administered together with new intravenous, containing regimens should be explored in the preoperative treatment of endocrine responsive breast cancer...
Intraoperative radiation therapy for breast cancer: technical notesUmberto Veronesi
Breast Department, European Institute of Oncology, Milan, Italy
Breast J 9:106-12. 2003..Here we report the two different techniques in use in these trials...
Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancerMonica Iorfida
Unit of Research in Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast 19:128-32. 2010..Combined trastuzumab and intravenous vinorelbine yielded high clinical activity as preoperative treatment in patients (pts) with HER 2/neu positive breast cancer...
Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of OncologyViviana Galimberti
Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy
Ann Surg 253:580-4. 2011..Our aim was to evaluate the influence of margin status on outcomes with a view assessing the appropriateness of conservative surgery in this breast cancer subtype...
Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patientsRoberto Gennari
Department of Surgery, European Institute of Oncology, Milan, Italy
Cancer 101:1302-10. 2004..The aim of the study was to evaluate the relation between biologic features at first diagnosis of breast carcinoma and treatment choice for postmenopausal women > or = 50 years to optimize treatment in the elderly...
The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the resultsAlberto Luini
Division of Breast Surgery, University of Milan, Milan, Italy
Breast Cancer Res Treat 93:55-9. 2005..At the European Institute of Oncology we started our study on ELIOT in 1999; the first step has been a phase I-II trial to test feasibility and tolerance of ELIOT in patients candidate to breast conserving surgery...
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgeryUmberto Veronesi
Office of the Scientific Director, Milan, Italy
Arch Surg 138:1253-6. 2003..Intraoperative RT delivered with electrons at the total isodose of 2100 rad (21 Gy) could in principle substitute the currently used radiation course of external RT after breast-conserving surgery in selected cases...
Report on a case of breast sarcoma metastatic to the axillary lymph nodesJack Antonio Diaz Brito
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Tumori 92:188-90. 2006..We report a case of a 65-year-old woman affected by follicular dendritic cell sarcoma of the left breast. Six months after breast surgery she developed an axillary metastasis from the same disease...
Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancerRosalba Torrisi
Research Unit of Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 16:73-80. 2007..Further studies combining chemotherapy and endocrine agents are warranted in patients with hormone receptor-positive tumors...
Conservative surgery in patients with multifocal/multicentric breast cancerOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 113:577-83. 2009..We retrospectively evaluate outcome of patients with MF/MC cancers who had breast conservation with specific attention on local control and predictive factors of recurrence...
In vivo dosimetry using radiochromic films during intraoperative electron beam radiation therapy in early-stage breast cancerMario Ciocca
Department of Medical Physics, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy
Radiother Oncol 69:285-9. 2003..CONCLUSIONS: Satisfactory agreement between measured and expected doses was found. The implementation of in vivo dosimetry in IOERT is suggested, particularly for patients enrolled in a clinical trial...
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trialViviana Galimberti
Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy Electronic address
Lancet Oncol 14:297-305. 2013..We designed IBCSG trial 23-01 to determine whether no axillary dissection was non-inferior to axillary dissection in patients with one or more micrometastatic (≤2 mm) sentinel nodes and tumour of maximum 5 cm...
Analysis of irradiated lung and heart volumes using virtual simulation in postoperative treatment of stage I breast carcinomaMaria Cristina Leonardi
Radiation Oncology Division, European Institute of Oncology, Milan, Italy
Tumori 89:60-7. 2003....
Male breast cancer: a special therapeutic problem. Anything new? (Review)Roberto Gennari
Department of Surgery, European Institute of Oncology, 20141 Milano, Italy
Int J Oncol 24:663-70. 2004....
Intraoperative radiotherapy: the debate continuesMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Lancet Oncol 5:340. 2004
Controversies in the use of sentinel nodes: microinvasion, post surgery and after preoperative systemic treatmentPaolo Veronesi
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast 16:S67-70. 2007..Here we discuss the suitability of SLNB in the settings of microinvasive cancer, after breast or axillary surgery and after neoadjuvant chemotherapy...
Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literatureAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 105:81-5. 2007..We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed...
Do clinicopathological features of the cancer patient relate with nipple areolar complex necrosis in nipple-sparing mastectomy?Visnu Lohsiriwat
Division of Plastic Surgery, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 20:990-6. 2013..The main complication of NSM is nipple areolar complex (NAC) necrosis, and it is usually related to surgical technique. However, the patients' clinicopathological factors should be also considered...
The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicatedJean Yves Petit
Plastic Surgery Division, European Institute of Oncology, Milan, Italy
Tumori 89:288-91. 2003..The nipple-sparing mastectomy is performed leaving 5 mm of glandular tissue behind the nipple areola complex to preserve its blood supply. The reconstruction is immediately performed with a prosthesis or an autologous flap...
Weekly epirubicin in the treatment of gestational breast cancer (GBC)Fedro A Peccatori
Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 115:591-4. 2009..GBC is a rare disease and chemotherapy in this setting lacks a standardized approach...
[Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), MailanW Gatzemeier
Division of Senology, European Institute of Oncology, Milan, Italy
Strahlenther Onkol 177:330-7. 2001..In published series it has been demonstrated that the external boost can be replaced by intraoperative radiotherapy (IORT) where irradiation at a single dose from 10 up to 15 Gy was safely delivered directly to the tumor bed...
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco
Nuclear Medicine, Radiology, Senology and Pathology Divisions, European Institute of Oncology, Milan, Italy
Q J Nucl Med 46:145-51. 2002..4%) benign lesions and 407 (52.6%) cancers. The cancers were treated by conservative breast surgery in 99.5% of cases. CONCLUSIONS: We concluded that ROLL enables the surgeon to remove occult breast lesions easily and reliably...
Technical tricks to improve the cosmetic results of breast-conserving treatmentJean Yves Petit
European Institute of Oncology, Department of Plastic and Reconstructive Surgery, Milan, Italy
Breast 16:13-6. 2007....
Selective sentinel lymph node biopsy and primary systemic therapy in breast cancerAntonio Piñiero
Department of Surgery, Virgen de la Arrixaca University Hospital, Murcia, Italy
Tumori 96:17-23. 2010..Timing and influence on sentinel lymph node biopsy result by primary systemic therapy are current and controversial topics...
Adenomyoepithelioma of the breast, presenting as a cancerGiovanna Gatti
Senology Division, European Oncology Institute, Milan, Italy
Tumori 90:337-9. 2004..Adenomyoepithelioma is a rare lesion that can involve the breast tissue. The diagnostic appearance of the lesion can give rise to a difficult differential diagnosis with breast carcinoma...
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal womenAliana Guerrieri-Gonzaga
Division of Chemoprevention, European Institute of Oncology, Milan, Italy
J Clin Oncol 24:129-35. 2006..CONCLUSION: The combination of low-dose tamoxifen and fenretinide is safe but not synergistic in lowering IGF-I levels in premenopausal women. The clinical implications require further follow-up...
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large seriesU Veronesi
Senology Division, Istituto Europeo di Oncologia, Milan, Italy
J Natl Cancer Inst 91:368-73. 1999....
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni
Research Unit in Medical Senology at the Department of Medicine, Istituto Europeo di Oncologia, Milan, Italy
Ann Oncol 18:1632-40. 2007..4%), focal (368, 14.1%), moderate (51, 2.0%) and extensive (170, 6.5%)...
Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesionsC De Cicco
Division of Nuclear Medicine, European Institute of Oncology and University of Milan, Milan, Italy
Eur J Nucl Med Mol Imaging 31:349-54. 2004....
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna
Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
Br J Cancer 98:1745-52. 2008..High degree of Ki-67 staining and presence of PVI were also indicators of higher risk of early relapse. These factors should be considered in therapeutic algorithms for LABC...
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcomeE Botteri
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Ann Oncol 20:1008-12. 2009..In the case of ipsilateral breast tumour recurrence (IBTR) after breast-conserving surgery (BCS), a second conservative surgical approach maybe considered in some motivated patients whereas in others mastectomy is unavoidable...
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni
Department of Medicine, Division of Medical Oncology, European Institute of Oncology, Milan, Italy
Ann Oncol 20:1178-84. 2009..We aimed to predict disease-free survival (DFS) in patients who failed to achieve a pathologic complete remission (pCR) after preoperative chemotherapy (PC)...
Internal mammary node lymphoscintigraphy and biopsy in breast cancerG Paganelli
Divisions of Nuclear Medicine, European Institute of Oncology, Milan, Italy
Q J Nucl Med 46:138-44. 2002..We investigated whether deep injection of tracer visualized internal mammary chain lymph (IMC) nodes more often, and assessed the impact of IMC status on disease staging...
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando
Division of Medical Oncology, European Institute of Oncology, Milan, Italy
Anticancer Res 21:4135-9. 2001....
Very young women (<35 years) with operable breast cancer: features of disease at presentationM Colleoni
Department of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 13:273-9. 2002..Breast cancer rarely occurs in young women. Our knowledge about disease presentation, prognosis and treatment effects are largely dependent upon older series...
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsM Colleoni
Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy
Ann Oncol 11:1057-9. 2000..To test this hypothesis we evaluated the responsiveness to preoperative chemotherapy in patients with ER and progesterone receptors (PgR)-absent tumors...
Preoperative systemic treatment: prediction of responsivenessM Colleoni
Department of Medicine, European Institute of Oncology, Milan, Italy
Breast 12:538-42. 2003..g. endocrine primary therapy) might be more useful...
[Conservative approach for breast cancer. The experience of the European Institute of Oncology]O Gentilini
Divisione di Senologia, Istituto Europeo di Oncologia di Milano, Milano
Minerva Chir 62:447-58. 2007..This conservative approach is completed by the possibility to deliver a partial breast irradiation and to provide patients with more personalized adjuvant treatments tailored on the biological features of the tumour...
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni
Research Unit in Medical Senology, Department of Medicine, Instituto Europeo di Oncologia, Milan, Italy
Ann Oncol 17:1497-503. 2006..There is limited knowledge about prognosis, and treatment effects in young women with node-negative disease...
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesU Veronesi
Division of Senology, European Institute of Oncology, Milan, Italy
Ann Oncol 18:473-8. 2007..The aim of this study was to compare SNB and -positron emission tomography (-PET) imaging, to assess their values in detecting occult axillary metastases...
Breast cancer diagnosed during pregnancy and lactation: biological features and treatment optionsO Gentilini
Department of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Eur J Surg Oncol 31:232-6. 2005..Assessment of biological features and treatment of patients with breast cancer presenting during pregnancy or lactation...
A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancerR Torrisi
Medical Senology Research Unit, Department of Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milan, Italy
Anticancer Res 26:3861-4. 2006..Dose-dense chemotherapy with anthracyclines and taxanes has improved either disease free survival or overall survival in high risk patients with early breast cancer...
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni
Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 15:1633-9. 2004..While data exist to clearly correlate small tumor size to better prognosis, the fact that very small breast cancers may express biological markers of dire prognosis leads many to ignore small tumor size during treatment decision-making...
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?O Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Ann Oncol 18:468-72. 2007..Mastectomy is considered the treatment of choice in patients with ipsilateral breast tumour recurrence (IBTR) after breast-conserving surgery (BCS)...
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyM Colleoni
Unit of Research in Medical Senology, Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 19:465-72. 2008..To identify the role of estrogen (ER), progesterone (PgR), epidermal growth factor 1 (HER1), and HER2 receptors in predicting response to preoperative chemotherapy...
Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institutionO Gentilini
Division of Breast Surgery, European Institue of Oncology, Milan, Italy
Ann Oncol 18:1342-7. 2007..The aim of this study was to describe outcomes of patients who underwent mastectomy without radiotherapy in a single institution...
Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancerR Orecchia
Division of Radiation Therapy, European Institute of Oncology, Milan, Italy
Breast 12:483-90. 2003..More than 400 patients have been enrolled. In addition a new approach for nipple and areola complex conservation, including ELIOT, is under investigation...
A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treatedU Veronesi
Radiotherapy Division, Istituto Europeo di Oncologia, University of Milan, Via G Ripamonti 435, 20141 Milan, Italy
Eur J Cancer 37:2178-83. 2001..However, a longer follow-up is needed for a better evaluation of the possible late side-effects...
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study GroupGiuseppe Viale
Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy
J Clin Oncol 26:1404-10. 2008....
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phaseM Colleoni
Department of Medicine, University of Milan School of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 14:1477-83. 2003....
Breast conservative treatment in association with implant augmentation and intraoperative radiotherapyM Rietjens
Department of Plastic and Reconstructive Surgery, European Institute of Oncology, EIO, Via Ripamonti 435, 20141 Milan, Italy
J Plast Reconstr Aesthet Surg 59:532-5. 2006..Cosmetic results are excellent and the patient is very satisfied. The surgical technique and the possible advantage of such a procedure are also discussed...
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna
Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 118:385-94. 2009..Treatment recommendations for systemic therapy should not take into account the presence of a single micrometastatic lymph node identified during complete serial sectioning of sentinel node(s)...
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozoleGiuseppe Viale
Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy
J Clin Oncol 26:5569-75. 2008..To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer...
The Veronesi quadrantectomy: an established procedure for the conservative treatment of early breast cancerS Zurrida
Division of Senology, Istituto Europeo di Oncologia, Milan, Italy
Int J Surg Investig 2:423-31. 2001..The article goes on to describe the surgical procedures of quadrantectomy and complete axillary dissection as developed by Veronesi, and outlines new indications for, and developments of this established conservative technique...
Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of OncologyO Gentilini
Division of Senology, European Institute of Oncology, Milano, Italy
Eur J Surg Oncol 32:507-10. 2006..To present our experience with sentinel lymph node biopsy (SLNB) performed in patients with multicentric breast cancer...
Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastasesEdoardo Botteri
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 138:303-10. 2013..In this large and homogeneous series of MBC patients with synchronous bone metastases, the role of breast surgery had a favorable impact on both disease progression and mortality...
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomyMaximiliano Cassilha Kneubil
Division of Plastic Reconstruction Surgery, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 19:4117-23. 2012..Our purpose was to evaluate the locoregional recurrence (LRR) of patients with false-negative, frozen-section or close margins of retroareolar specimen in nipple-sparing mastectomy (NSM) procedure...
Long-term oncological results of breast conservative treatment with oncoplastic surgeryM Rietjens
Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
Breast 16:387-95. 2007..53%). Patients with tumours larger than 2 cm were at greater risk of local recurrences and distant metastasis. Long-term oncologic results of BCT with oncoplastic surgery are comparable with the results of BCT randomized trials...
Sentinel lymph node biopsy for localised ductal carcinoma in situ?P Veronesi
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy
Breast 14:520-2. 2005..If the SLN is micrometastatic complete axillary dissection is not unavoidable...
Re: Trends in the treatment of ductal carcinoma in situ of the breastMattia Intra
J Natl Cancer Inst 96:1110-1. 2004
Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of OncologyMattia Intra
Eur J Nucl Med Mol Imaging 34:957-8. 2007
Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy usersVirgilio Sacchini
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 9:266-71. 2002..Breast cancer tumors occurring in hormone replacement therapy (HRT) users are less aggressive, but no studies have compared tumor aggressiveness among HRT users by length and mode of therapy...
Breast cancer among HIV-infected patients: the experience of the European Institute of OncologyMattia Intra
J Surg Oncol 91:141-2. 2005
